Brief: Edesa Biotech Inc Announces Positive Phase 2 Data Of Its Monoclonal Antibody
20/09/2021 14:22
Sept 20 (Reuters) - Edesa Biotech Inc EDSA.O :
* EDESA BIOTECH ANNOUNCES POSITIVE PHASE 2 DATA OF ITS
MONOCLONAL
ANTIBODY IN HOSPITALIZED COVID-19 PATIENTS
* EDESA BIOTECH INC - STUDY UNBLINDED DUE TO STRONG EFFICACY
SIGNAL FOR 28-DAY MORTALITY ENDPOINT
* EDESA BIOTECH INC - CRITICALLY ILL PATIENTS DEMONSTRATED A
68.5%
REDUCTION IN THE RISK OF DYING WHEN TREATED WITH EB05 OVER
STANDARD OF CARE
Further company coverage: EDSA.O